Sphera Funds Management »

Alto Neuroscience shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Alto Neuroscience shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $468k 31k 15.35

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sanofi Sponsored Adr (SNY)
Nice Sponsored Adr (NICE)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Syndax Pharmaceuticals (SNDX)
Biogen Idec (BIIB)
Jasper Therapeutics Com New (JSPR)
IsoRay (CATX)
Ultragenyx Pharmaceutical (RARE)
Merck & Co (MRK)
Kura Oncology (KURA)
Astrazeneca Sponsored Adr (AZN)
Sentinelone Cl A (S)

View all positions for Sphera Funds Management

Top funds holding Alto Neuroscience

FMR
RA Capital Management
Point72 Asset Management
72 Investment Holdings
T. Rowe Price Associates
Franklin Resources
ExodusPoint Capital Management
Vanguard Group
Jennison Associates
Artal Group
Board of Trustees of The Leland Stanford Junior University
AWM Investment Company
Citadel Advisors
Valor Management
BlackRock

View all funds holding Alto Neuroscience